Two individuals will be prosecuted shortly in Shanghai for conducting illegal investigations and purchase of personal information in China.

The Chinese Food and Drug Administration ("CFDA") recently published a draft circular to address the more than 21,000 drug applications that have been submitted for agency review.

In May 2015, China's Food and Drug Administration ("CFDA") announced it is raising the registration fees imposed on pharmaceutical drugs and medical devices.

The Asia-Pacific Economic Cooperation held a High-Level Policy Dialogue on Agricultural Biotechnology in Dalian, China, where participants explored how genome technologies are transforming food production across the region. Experts demonstrated innovations ranging from fish bred with fewer bones to rice varieties designed for diabetic populations, while addressing the critical challenge of public perception and regulatory frameworks. The dialogue emphasized science-based regulation and consumer education as

China continues to struggle in its efforts to improve food safety regulation and oversight, in the wake of a succession of food safety problems.

In September 2015, China's National Health and Family Planning Commission ("NHFPC") issued a Three-Year Action Plan for Treating Cancer (2015–2017).

After receiving comments on the draft of the Decision of the State Administration of Food and Drug Administration on Adjusting the Relevant Issues Concerning the Registration and Administration...

Beijing Taide Pharmacy Limited Company (北京泰德制药有限公司) is challenging Pfizer. The drug at issue is Palbociclib capsule 125mg, for treating HR-positive and HER2-negative breast cancer (for personal reason, this is of big concern to myself).

The Guidelines also require that the production date and use by period of the health food be clearly marked on the sales package, along with the producer's service hotline.

On the afternoon of July 28, under the witness of Premier Li Qiang of the State Council and Italian Prime Minister Giorgia Meloni, the Memorandum of Understanding...

海南博鳌乐城国际医疗旅游先行区（以下简称"先行区"）是2013年国务院批准设立的全国唯一的医疗领域对外开放的医疗产业园区，被誉为"博鳌亚ė

OFAC designated the China-based Zheng Drug Trafficking Organization ("Zheng DTO") and Chinese nationals Zheng Fujing and Yan Xiaobing

After the State Council issued the Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation of Drugs and Medical Devices ("Opinions") on 8 October 2017, ...

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab).

We first reported on MAILISHU's approval on Big Molecule Watch's China blog.

CCTV has reported that in order to achieve long-term profits, many milk companies had bribed doctors and nurses.

Beijing Higher People's Court in a recent judgment holds that a Markush claim may include multiples technical solutions and thus may claim partial priority, i.e. some of the technical solutions...

During Chinese President Xi Jinping's visit to France, the China National Intellectual Property Administration (CNIPA), together with the Ministry of Agriculture and Food Sovereignty of the French

The platform can be visited at https://zldj.cde.org.cn and is open for public testing from May 18, 2021 to May 31, 2021.

最近、国家薬品監督管理局・薬品審査評価センターは「医薬品特許をめぐる紛争の早期解決メカニズムに関する特許情報登録プラットフォ